期刊文献+

1例宫颈癌患者化疗后呕吐的病例分析

A case analysis of post-chemotherapy vomiting in a patient with cervical cancer
下载PDF
导出
摘要 临床药师通过对1例宫颈癌患者化疗后呕吐的原因及危险因素分析,对患者后续的药物预防和治疗方案提出合理化建议,并总结药学监护内容,为化疗所致的恶心呕吐(CINV)的规范化管理提供参考。临床药师应融入医疗团队中,发挥药学专业专长,开展个体化药物治疗管理,为患者提供相应的药学监护及用药教育,促进临床合理用药,同时提升药师在临床的实践能力,使临床药师和医院药学得到长远的发展。 By analyzing the causes and risk factors of post-chemotherapy vomiting in a cervical cancer patient,the clinical pharmacist make rationalized suggestions for the patient's subsequent drug prevention and treatment plan,and summarize the contents of pharmacological monitoring to provide reference for the standardized management of chemotherapy-induced nausea and vomiting(CINV).Clinical pharmacists should be integrated into the medical team,give full play to their pharmaceutical expertise,carry out individualized drug therapy management,provide patients with corresponding pharmacological monitoring and medication education,promote rational clinical use of drugs,and at the same time enhance the practical ability of pharmacists in the clinic so that clinical pharmacists and hospital pharmacy can be developed in the long term.
作者 杜松 高绍山 杜良 DU Song;GAO Shao-shan;DU Liang(Department of Pharmacy,Tai'an Central Hospital(Tai'an Central Hospital and Taishan Medical and Nursing Center Affiliated to Qingdao University),Tai'an 271000,China)
出处 《中国实用医药》 2023年第11期160-162,共3页 China Practical Medicine
关键词 宫颈癌 化疗 呕吐 病例分析 Cervical cancer Chemotherapy Vomiting Case analysis
  • 相关文献

参考文献7

二级参考文献70

  • 1张利东,梁蔓逸,黄晓忠.福沙匹坦三联止呕药预防高致呕化疗方案所致恶心呕吐疗效观察[J].黑龙江中医药,2021,50(2):168-169. 被引量:2
  • 2吴海福,童赛雄,凌跃新,吴肇汉.胃大部分切除术后胃潴留的营养支持[J].中国临床医学,2005,12(4):618-619. 被引量:3
  • 3张晓静,张频.肿瘤化疗所致恶心呕吐的发生机制和药物治疗的研究进展[J].癌症进展,2006,4(4):348-354. 被引量:126
  • 4Richard JG.New agents,new treatment and antiemetic therapy[J].Semin Oncol,2002,29(Suppl 4):S119-S124.
  • 5Navari RM,Gray SE,Kerr AC.Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting:a randomized phaseⅢtria[lJ].J Support Oncol,2011 Sep-Oct,9(5):188-95.
  • 6Grunberg SM, Deuson RR, Mavros P,et al. Incidence of chemother- apy-induced nausea and emesisafter modern antiemetics[ J]. Canc- er, 2004,100 ( 10 ) : 2261 - 2268.
  • 7Tsukahara K, Nakamura K, Motohashi R, et al. Antiemetic therapy of fosaprepitant, palonosetrou, and dexamethasone combined with cisplatin-based chemotherapy for head and neck carcinomas [ J]. Acta Otolaryngo1,2014,134 ( 11 ) : 1198 - 1204.
  • 8Ballatori E,Roila F, Ruggeri B,et al. The impact of chemotherapy- induced nausea and vomiting on health-relatedquality of life [ J ]. Support Care Cancer,2007,15 (2) :179 -185.
  • 9M assaro AM,Lenz KL. Aprepitant:A novel antiemetic for chemo- therapy-induced nausea and vomiting [ J ]. Ann Pharmaeother, 2005,39 ( 1 ) :77 - 85.
  • 10Warr DG, Hesketh PJ, G ralla R J, et al. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy[ J]. J Clin Oncol,2005,23(12) :2822 -2830.

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部